trending Market Intelligence /marketintelligence/en/news-insights/trending/l3Unk043-6Vzmh8Enr5Lrg2 content esgSubNav
In This List

Regenxbio appoints chief scientific officer

Blog

Funding Social and Affordable Housing: A Credit Perspective

Blog

Global M&A By the Numbers: Q2 2021

Blog

Global Capital Markets & SPAC Activity – H1 2021

Blog

Gauging Supply Chain Risk In Volatile Times


Regenxbio appoints chief scientific officer

Regenxbio Inc. appointed Olivier Danos to the newly created position of chief scientific officer.

Danos will be reporting to Kenneth Mills, the company's president and CEO. Danos was most recently the senior vice president of cell and gene therapy at Biogen Inc.